801 related articles for article (PubMed ID: 30382595)
1. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
[TBL] [Abstract][Full Text] [Related]
2. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
[TBL] [Abstract][Full Text] [Related]
3. The TAM-associated STIM1
Kim JH; Carreras-Sureda A; Didier M; Henry C; Frieden M; Demaurex N
Cell Calcium; 2022 Jul; 105():102615. PubMed ID: 35792400
[TBL] [Abstract][Full Text] [Related]
4. Calcium entry units (CEUs): perspectives in skeletal muscle function and disease.
Protasi F; Pietrangelo L; Boncompagni S
J Muscle Res Cell Motil; 2021 Jun; 42(2):233-249. PubMed ID: 32812118
[TBL] [Abstract][Full Text] [Related]
5. Authentic CRAC channel activity requires STIM1 and the conserved portion of the Orai N terminus.
Derler I; Butorac C; Krizova A; Stadlbauer M; Muik M; Fahrner M; Frischauf I; Romanin C
J Biol Chem; 2018 Jan; 293(4):1259-1270. PubMed ID: 29237734
[TBL] [Abstract][Full Text] [Related]
6. CRAC channel opening is determined by a series of Orai1 gating checkpoints in the transmembrane and cytosolic regions.
Tiffner A; Schober R; Höglinger C; Bonhenry D; Pandey S; Lunz V; Sallinger M; Frischauf I; Fahrner M; Lindinger S; Maltan L; Berlansky S; Stadlbauer M; Schindl R; Ettrich R; Romanin C; Derler I
J Biol Chem; 2021; 296():100224. PubMed ID: 33361160
[TBL] [Abstract][Full Text] [Related]
7. Ca
Bhardwaj R; Augustynek BS; Ercan-Herbst E; Kandasamy P; Seedorf M; Peinelt C; Hediger MA
Cell Physiol Biochem; 2020 Mar; 54(2):252-270. PubMed ID: 32176842
[TBL] [Abstract][Full Text] [Related]
8. Diseases caused by mutations in ORAI1 and STIM1.
Lacruz RS; Feske S
Ann N Y Acad Sci; 2015 Nov; 1356(1):45-79. PubMed ID: 26469693
[TBL] [Abstract][Full Text] [Related]
9. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
[TBL] [Abstract][Full Text] [Related]
10. Pore properties of Orai1 calcium channel dimers and their activation by the STIM1 ER calcium sensor.
Cai X; Nwokonko RM; Loktionova NA; Abdulqadir R; Baraniak JH; Wang Y; Trebak M; Zhou Y; Gill DL
J Biol Chem; 2018 Aug; 293(33):12962-12974. PubMed ID: 29954946
[TBL] [Abstract][Full Text] [Related]
11. Role of STIM1/ORAI1-mediated store-operated Ca
Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between N-terminal and C-terminal domains in stromal interaction molecule 2 (STIM2) determines enhanced STIM2 sensitivity.
Emrich SM; Yoast RE; Xin P; Zhang X; Pathak T; Nwokonko R; Gueguinou MF; Subedi KP; Zhou Y; Ambudkar IS; Hempel N; Machaca K; Gill DL; Trebak M
J Biol Chem; 2019 Apr; 294(16):6318-6332. PubMed ID: 30824535
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of Orai1 channels by STIM proteins.
Zhou Y; Nwokonko RM; Cai X; Loktionova NA; Abdulqadir R; Xin P; Niemeyer BA; Wang Y; Trebak M; Gill DL
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3398-E3407. PubMed ID: 29581306
[TBL] [Abstract][Full Text] [Related]
14. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
Feske S
Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
[TBL] [Abstract][Full Text] [Related]
15. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.
Endo Y; Noguchi S; Hara Y; Hayashi YK; Motomura K; Miyatake S; Murakami N; Tanaka S; Yamashita S; Kizu R; Bamba M; Goto Y; Matsumoto N; Nonaka I; Nishino I
Hum Mol Genet; 2015 Feb; 24(3):637-48. PubMed ID: 25227914
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
Böhm J; Laporte J
Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
[TBL] [Abstract][Full Text] [Related]
18. A pathogenic human Orai1 mutation unmasks STIM1-independent rapid inactivation of Orai1 channels.
Yeung PS; Yamashita M; Prakriya M
Elife; 2023 Feb; 12():. PubMed ID: 36806330
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
